These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 925187)

  • 1. The role of clinical guidelines in research: FDA's viewpoint.
    Freeman MM
    J Clin Pharmacol; 1977; 17(11-12):682-5. PubMed ID: 925187
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug industry trying to change FDA's slow but sure policy.
    Demkovich LE
    Natl J (Wash); 1979 Jul; 11(29):1211-5. PubMed ID: 10242491
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of FDA's new drug rule? Not much.
    Holthaus D
    Hospitals; 1987 Aug; 61(15):106. PubMed ID: 3596532
    [No Abstract]   [Full Text] [Related]  

  • 4. The FDA's restrictions against prescription drug advertising: more hindrance than help.
    Lorman AJ
    Healthspan; 1991 Nov; 8(10):3-7. PubMed ID: 10114942
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA's role in drug product recalls.
    Crawford SY
    Am J Hosp Pharm; 1991 Dec; 48(12):2595-6. PubMed ID: 1814194
    [No Abstract]   [Full Text] [Related]  

  • 6. Federal Right-to-Try Legislation - Threatening the FDA's Public Health Mission.
    Joffe S; Lynch HF
    N Engl J Med; 2018 Feb; 378(8):695-697. PubMed ID: 29320302
    [No Abstract]   [Full Text] [Related]  

  • 7. The FDA's critical path initiative: a brief introduction.
    Coons SJ
    Clin Ther; 2009 Nov; 31(11):2572-3. PubMed ID: 20110002
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessing supplement safety--the FDA's controversial proposal.
    Cohen PA
    N Engl J Med; 2012 Feb; 366(5):389-91. PubMed ID: 22276780
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulatory experts debate FDA's authority.
    Young D
    Am J Health Syst Pharm; 2007 May; 64(9):910, 912. PubMed ID: 17468140
    [No Abstract]   [Full Text] [Related]  

  • 10. Kelsey's Commandos: FDA investigates the investigators.
    Small WE
    Am Pharm; 1979 Jun; 19(6):30-3. PubMed ID: 463736
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA's aseptic processing: proposed regulation.
    Barr DB
    J Parenter Sci Technol; 1993; 47(2):57-9. PubMed ID: 8515345
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA's regulation of prescription drug labeling: a role for implied preemption.
    Kendrick LC
    Food Drug Law J; 2007; 62(1):227-47. PubMed ID: 17444031
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiarrhythmic drug approval--an industry perspective.
    Jacobs S
    Can J Cardiol; 1991; 7(1):45-6; discussion 49-50. PubMed ID: 2025792
    [No Abstract]   [Full Text] [Related]  

  • 14. The current status of guidelines for clinical research from the viewpoint of the pharmaceutical industry.
    Dixon RB
    J Clin Pharmacol; 1977; 17(11-12):691-6. PubMed ID: 925189
    [No Abstract]   [Full Text] [Related]  

  • 15. A prescription for monitoring drugs.
    Marshall E
    Science; 1980 Feb; 207(4433):853-5. PubMed ID: 7355265
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA's interferon-beta decision reignites orphan debate.
    Marshall A
    Nat Biotechnol; 1999 Apr; 17(4):324-5. PubMed ID: 10207871
    [No Abstract]   [Full Text] [Related]  

  • 17. Export of pharmaceuticals and medical devices under the federal Food, Drug & Cosmetic Act: FDA's striking change in interpretation post-Shelhigh.
    Basile EM; Tolomeo D; Gluck E
    Food Drug Law J; 2009; 64(1):149-69. PubMed ID: 19998744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Food and Drug Administration's requirements for approval of new dental drugs.
    Gilkes CC
    Symp Pharmacol Ther Toxicol Group; 1975 Apr; ():5-12. PubMed ID: 1064180
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA's Bioresearch Monitoring Program.
    Kelsey FO
    Methods Find Exp Clin Pharmacol; 1982; 4(7):503-8. PubMed ID: 7169836
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA's perspective on women and drugs.
    Danello MA
    NIDA Res Monogr; 1986; 65():9-13. PubMed ID: 3090447
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.